Pressroom

A new USC Schaeffer Center study finds that how vaccines are allocated may contribute to vaccine hesitant individuals later refusing the vaccine when it is made available to them.

A new white paper published by the USC Schaeffer Center focuses on the potential benefit of multi-cancer early detection (MCED) blood-based tests to reduce disparities in late-stage cancer diagnosis among minority populations.

A new white paper finds private sector influence combined with market-side demand for mandates will overcome state laws that have limited vaccine requirements thus far.

Though the study of racially diverse Medicaid patients indicated disproportionate risk among Latinos, USC researchers say it can’t be explained by higher rates of poverty or underlying health factors like obesity.

Researchers found adults were incentivized to exercise more often for the same anticipated cash reward simply by changing how the reward is delivered.

Intermediaries negotiate good prices, but lack incentives to pass savings to beneficiaries and taxpayers.

A Medicaid-Medicare partnership could cover lifesaving hepatitis C medications — and still save $1 to $1.1 billion over 25 years

The relationship between approvals and future innovation is unclear at best. As such, the FDA should continue to base its decisions solely on safety and efficacy, rather than speculative long-term innovation effects.

Jehan Sparks helped design the top-performing “nudge” which resulted in an 11% increase in the rate of flu shot vaccinations.

Targeted therapies accounted for about 90% of new active substance approvals in oncology between 2011 and 2018.